SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

I Vicenti, M Zazzi, F Saladini - Expert Opinion on Therapeutic …, 2021 - Taylor & Francis
ABSTRACT Introduction: The current SARS-CoV-2 pandemic urgently demands for both
prevention and treatment strategies. RNA-dependent RNA-polymerase (RdRp), which has …

Pathogenicity and virulence of Marburg virus

MH Abir, T Rahman, A Das, SN Etu, IH Nafiz, A Rakib… - Virulence, 2022 - Taylor & Francis
Marburg virus (MARV) has been a major concern since 1967, with two major outbreaks
occurring in 1998 and 2004. Infection from MARV results in severe hemorrhagic fever …

Pharmacological treatment of COVID-19: an opinion paper

A García-Lledó, J Gómez-Pavón… - Revista Española …, 2021 - pmc.ncbi.nlm.nih.gov
The precocity and efficacy of the vaccines developed so far against COVID-19 has been the
most significant and saving advance against the pandemic. The development of vaccines …

An introduction to the Marburg virus vaccine consortium, MARVAC

RW Cross, IM Longini, S Becker, K Bok… - PLoS …, 2022 - journals.plos.org
The emergence of Marburg virus (MARV) in Guinea and Ghana triggered the assembly of
the MARV vaccine “MARVAC” consortium representing leaders in the field of vaccine …

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control

S Wang, W Li, Z Wang, W Yang, E Li, X Xia… - Signal transduction and …, 2024 - nature.com
To adequately prepare for potential hazards caused by emerging and reemerging infectious
diseases, the WHO has issued a list of high-priority pathogens that are likely to cause future …

[HTML][HTML] Marburg virus disease: a summary for clinicians

MG Kortepeter, K Dierberg, ES Shenoy… - International Journal of …, 2020 - Elsevier
Objectives This article summarizes the countermeasures for Marburg virus disease, focusing
on pathogenesis, clinical features and diagnostics. There is an emphasis on therapies and …

Marburg virus disease: a deadly rare virus is coming

F Zhao, Y He, H Lu - Bioscience trends, 2022 - jstage.jst.go.jp
Two cases of the deadly Marburgvirus were reported in Ghana, which might be a new global
virus alert following COVID-19 and novel monkeypox. Thus far, there is no vaccine or …

Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges

S Srivastava, D Sharma, S Kumar, A Sharma… - Frontiers in …, 2023 - frontiersin.org
The Marburg virus (MV), identified in 1967, has caused deadly outbreaks worldwide, the
mortality rate of Marburg virus disease (MVD) varies depending on the outbreak and virus …

Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates

RW Cross, C Woolsey, AN Prasad, V Borisevich… - Nature Medicine, 2025 - nature.com
The recent outbreak of Marburg virus (MARV) in Rwanda underscores the need for effective
countermeasures against this highly fatal pathogen, with case fatality rates reaching 90 …

Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro

SR Radoshitzky, P Iversen, X Lu, J Zou, SJF Kaptein… - Scientific reports, 2023 - nature.com
Abstract Remdesivir (GS-5734; VEKLURY) is a single diastereomer monophosphoramidate
prodrug of an adenosine analog (GS-441524). Remdesivir is taken up by target cells and …